Robot surgery finding new uses April 07, 2009 ![]() Another story about the growing uses for robotic surgery. But the story gave no data or evidence, framed it like playing video games, and failed to put into context of other available procedures. Our Review Summary
This was another story about the growing uses for robotic surgery. And it was another story that read like an ad for the DaVinci robotic system. This one focused on bladder surgery. Good points: the story discussed patient cost and insurance coverage and mentioned the expense of the equipment and the physician training required.
Even with prostate cancer, for which robotic systems have been used most often, the US Agency for Healthcare Research and Quality says there isn’t enough research yet to tell us how well robotic surgery works compared with other treatments. That should have been part of this story. Somewhere between "video games" and "shooting at space ships."
Click on Criteria for definitions. The story states that the robotic surgical systems have popped up at 1,000 hospitals worldwide in the past 5 years. However, this implies that the procedure (robot assisted laparoscopic cystectomy) is similarly available. This is not likely to be the case. A recent review of the literature suggests that approximately 350 cases have been reported to date. The story appropriately notes that the University of Miami is one of the few centers using the DaVinci for this purpose. ![]() Discuss costs? - SATISFACTORY
The story states: "private insurance pays for the $50,000 operation." ![]() Avoid "disease-mongering"? - NOT APPLICABLE
There really isn't any substantive discussion about the condition(s) for which the robotic system is used. ![]() Evaluate the quality of evidence? - NOT SATISFACTORY
A major shortcoming of the story: no evidence was discussed - only one surgeon's experience. But no discussion of evidence or data. In fact, the absolute value of robot assisted laparoscopic surgery compared to laparoscopic surgery and open procedures is unclear at the present time. While there may be short term advantages to laparoscopic surgery (robot assisted and non-robot assisted) over open procedures, the long term functional outcomes are unknown for bladder removal due to cancer. In addition, the ability to remove all cancer present using laparoscopic procedures is also an open question when compared to the open and traditional approach. The story provides a single and presumably somewhat biased informant (the surgeon doing the surgery) to validate the technique. ![]() Quantify the potential harms? - NOT SATISFACTORY
No discussion of evidence on harms. But in a story that frames this - through the surgeon's words - as like "video games....like shooting at space ships" - perhaps this is understandable. That surgeon says the system is "more precise...there's less pian. less blood and a shorter recovery time." But no evidence is provided to support that. The possible short term gains of less pain, less blood and shorter recovery time need to be balanced against the possible harms of an incomplete cancer removal and a possible recurrence of the cancer. The story gives some background on the history of, and other uses for, robotic surgery and states "robotic surgery isn't new." ![]() Quantify the potential benefits? - NOT SATISFACTORY
Again, no data nor evidence for efficacy were presented. ![]() Appear to rely solely or largely on a news release? - SATISFACTORY
Does not appear to rely on a news release. ![]() Use independent sources and identify conflicts of interest? - NOT SATISFACTORY
Besides the Miami surgeon profiled, a Mayo surgeon was interviewed. But both are robotic system users. No truly independent source was interviewed. ![]() Compare the new approach with existing alternatives? - NOT SATISFACTORY
No meaningful substantive comparison with other approaches was included. Total Score: 4 of 9 Satisfactory The U.S. Preventive Services Task Force is considered the gold standard of preventive health recommendations - including on screening tests. It's a good source for journalists and consumers.
About 70% of the stories reviewed from 2006-9 failed to adequately discuss costs, or to explain how big (or small) are the potential benefits and harms of treatments, tests, products and procedures.
We have documented a disturbing trend of news stories taking an advocacy stance, promoting certain screening tests outside the boundaries of scientific evidence.
Stories on new technologies like Cyberknife, DaVinci robotic surgery systems, and proton beam cancer therapy often fail to scrutinize the evidence and/or to discuss the costs involved.
Rather than suggesting that everyone should be screened for everything, news stories could explain: "All screening tests cause harm; some may do good."
The first 38 network TV network morning health news stories reviewed in 2009 earned an average score of 1.2 stars. 13 of the 38 stories got ZERO stars.
Both TIME magazine and BusinessWeek have published terrific stories explaining the importance of the Number Needed to Treat - or NNT.
Knowing relative risk reduction is like knowing you have a 50% off coupon but not knowing whether it's for a Lexus or a lollipop. Absolute risk reduction tells you what the "coupon" is worth. Read more.
The website NoFreeLunch.org posts "a database of health care professionals who have pledged to accept no gifts from industry and to rely on non-promotional sources of information."
To help journalists cover stories responsibly, we post a list of independent experts who state that they do not have financial ties to drug or medical device manufacturers.
We apply the same ten standardized criteria to the review of every story.
We have about 30 story reviewers. Each story is reviewed by 3 different people.
Gary Schwitzer's seven words you shouldn't use in medical news: cure, miracle, breakthrough, promising, dramatic, hope, victim. Read why.
|